OA
SCMP

OFI Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

OFI Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$15K Sell
762
-815
-52% -$18.7K ﹤0.01% 1680
2015
Q2 		$26K Buy
+1,577
New +$27.3K ﹤0.01% 1654

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

OFI Advisors's SCMP Position: Q3 2015 in Review

OFI Advisors reduced its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 52% in Q3 2015, selling an estimated $18.7K and leaving 762 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

OFI Advisors first reported a position in SCMP in Q2 2015 and has held it in 2 quarters since. The position peaked at $26K in Q2 2015. 154 funds tracked by Wall St. Rank hold SCMP as of Q3 2015.

  • OFI Advisors held 762 shares of Sucampo Pharmaceuticals, Inc. worth $15K as of Q3 2015.
  • OFI Advisors sold 815 Sucampo Pharmaceuticals, Inc. shares in Q3 2015, an estimated $18.7K.
  • Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of OFI Advisors's portfolio in Q3 2015, its #1680 holding.
  • OFI Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and has held it in 2 quarters since.
  • OFI Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $26K in Q2 2015.
  • 154 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.